Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.

  • Authors:
    • S Rizzo
  • View Affiliations

  • Published online on: May 1, 1998     https://doi.org/10.3892/or.5.3.667
  • Pages: 667-738
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prognosis and survival of unresectable lung cancer patients is poor. The 5-year survival varies from 3 to 15% without relevant differences between treated and non-treated patients. The 2-year survival of comparable patients treated with chemo-radiotherapy (CH-RT) (n=63) and thermotherapy (RFT) (n=40) was studied. The 2-year follow-up survival curves did not differ for the groups in general but the survival time was longer for stage IV and non-small cell lung cancer in the RFT-group (13.2 mo and 13.4 mo, respectively) compared with CH-RT-group (8.4 mo and 9.6 mo, respectively). The difference was highly statistically significant (p<0.005).

Related Articles

Journal Cover

May-Jun 1998
Volume 5 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Rizzo S: Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.. Oncol Rep 5: 667-738, 1998
APA
Rizzo, S. (1998). Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.. Oncology Reports, 5, 667-738. https://doi.org/10.3892/or.5.3.667
MLA
Rizzo, S."Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.". Oncology Reports 5.3 (1998): 667-738.
Chicago
Rizzo, S."Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.". Oncology Reports 5, no. 3 (1998): 667-738. https://doi.org/10.3892/or.5.3.667